Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,003 | 878 | 97.4% |
| Education | $402.86 | 6 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,732 | 140 | $0 (2024) |
| Janssen Biotech, Inc. | $1,893 | 153 | $0 (2024) |
| LEO Pharma Inc. | $1,005 | 67 | $0 (2024) |
| PFIZER INC. | $954.80 | 69 | $0 (2024) |
| Lilly USA, LLC | $832.06 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $796.90 | 50 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $789.33 | 43 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $687.57 | 30 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $661.70 | 35 | $0 (2024) |
| Amgen Inc. | $608.08 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,303 | 101 | ABBVIE INC. ($499.89) |
| 2023 | $2,263 | 121 | AbbVie Inc. ($533.01) |
| 2022 | $2,895 | 171 | ABBVIE INC. ($723.22) |
| 2021 | $2,089 | 123 | AbbVie Inc. ($406.44) |
| 2020 | $1,608 | 89 | Janssen Biotech, Inc. ($296.91) |
| 2019 | $1,782 | 106 | AbbVie, Inc. ($271.43) |
| 2018 | $1,196 | 87 | Janssen Biotech, Inc. ($423.38) |
| 2017 | $1,269 | 86 | Janssen Biotech, Inc. ($586.49) |
All Payment Transactions
884 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.78 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Dermatology | ||||||
| 12/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.72 | General |
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Immunology | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.53 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,937 | 6,862 | $1.3M | $311,284 |
| 2022 | 19 | 3,919 | 7,012 | $1.4M | $319,302 |
| 2021 | 23 | 4,205 | 7,526 | $1.4M | $352,796 |
| 2020 | 19 | 3,754 | 6,819 | $860,520 | $296,523 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,706 | 2,640 | $755,355 | $154,161 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 526 | 585 | $134,550 | $37,817 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 390 | 452 | $90,400 | $20,001 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 199 | 230 | $64,400 | $17,439 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 154 | $50,820 | $14,997 | 29.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 144 | 158 | $44,740 | $14,948 | 33.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 343 | 2,050 | $41,000 | $10,822 | 26.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 68 | 83 | $35,690 | $10,416 | 29.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 33 | 33 | $28,215 | $8,299 | 29.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 99 | 111 | $18,875 | $3,969 | 21.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 84 | $12,180 | $3,845 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $15,390 | $3,786 | 24.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 54 | $8,100 | $2,206 | 27.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 20 | $14,000 | $2,103 | 15.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $6,000 | $1,767 | 29.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 14 | 14 | $4,480 | $1,242 | 27.7% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 13 | 56 | $5,600 | $1,047 | 18.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 11 | 12 | $2,037 | $1,002 | 49.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 12 | $3,960 | $807.38 | 20.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 22 | $3,410 | $588.24 | 17.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 26 | $130.00 | $21.51 | 16.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,780 | 2,918 | $838,650 | $171,544 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 515 | 577 | $132,710 | $37,572 | 28.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 403 | 470 | $94,000 | $21,591 | 23.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 162 | 185 | $51,140 | $14,351 | 28.1% |
About Dr. Jonathan Zirn, MD
Dr. Jonathan Zirn, MD is a Dermatology healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306896287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Zirn, MD has received a total of $15,406 in payments from pharmaceutical and medical device companies, with $2,303 received in 2024. These payments were reported across 884 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($15,003).
As a Medicare-enrolled provider, Zirn has provided services to 15,815 Medicare beneficiaries, totaling 28,219 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Danbury, CT
- Active Since 05/11/2006
- Last Updated 07/06/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1306896287
Products in Payments
- SKYRIZI (Biological) $1,116
- DUPIXENT (Biological) $1,028
- EUCRISA (Drug) $922.63
- RINVOQ (Biological) $912.08
- TALTZ (Drug) $808.29
- Tremfya (Drug) $653.90
- ADBRY (Biological) $514.99
- REMICADE (Biological) $508.16
- COSENTYX (Biological) $486.13
- Enbrel (Biological) $445.79
- ENSTILAR (Drug) $429.47
- Sotyktu (Drug) $424.07
- ILUMYA (Biological) $413.83
- STELARA (Biological) $367.27
- TREMFYA (Drug) $363.42
- AMZEEQ (Drug) $326.91
- Humira (Biological) $322.20
- OPZELURA (Drug) $316.84
- Cimzia (Drug) $287.04
- JUBLIA (Drug) $279.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Danbury
Ms. Mona Gohara, Md, MD
Dermatology — Payments: $243,572
William Notaro, Md, MD
Dermatology — Payments: $74,888
Mr. Graeme Lipper, Md, MD
Dermatology — Payments: $26,582
Ms. Grace Federman, Md, MD
Dermatology — Payments: $11,380
Dr. Marimeg Clairwood, M.d, M.D
Dermatology — Payments: $5,407
Dmitriy Timerman
Dermatology — Payments: $4,673